| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.01 | 0.9 |